Deloitte Legal assisted V-Bio Ventures, Qbic III and VIB with their 4 million funding round in Tanai Therapeutics. Flanders’ leading life sciences institute, VIB, has launched...
Tanai Therapeutics’ €4m Funding Round
Sibylla Biotech’s €23 Million Round Financing
Alma STA advised Sibylla Biotech in the legal aspects of the transaction, while V-Bio Ventures and CDP Venture Capital were assisted by BonelliErede. Sibylla Biotech, spin-off...
AstriVax’s Record-breaking €30 Million Seed Round
Quinz represented the investor syndicate led by V-Bio Ventures and FundPlus on the deal. The investor syndicate led by V-Bio Ventures and FundPlus completed the negotiation and...
V-Bio Ventures’ Third closing of V-Bio Fund 2
Eubelius assisted V-Bio Ventures with the deal. V-Bio Ventures increased the capital of its second fund, V-Bio Fund 2, to EUR 96 million. In order to internationalise this fundraising, V-Bio...
Coave Therapeutics’ €21 Million Funding Round
IN BRIEF: Bird & Bird, McDermott Will & Emery, Weil, Gotshal & Manges, advised on the matter. Bird & Bird advised Coave Therapeutics (Horama SAS) with...